Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.
Romanian consumers are becoming increasingly pessimistic about the country's economic and political outlook while continuing to prioritise spending and aggressively seek value, according to the latest Consumer Sentiment Survey by Boston Consulting Group (BCG).
Romanians spent €63 million in cinemas in 2025, a record level for the local market, reflecting a 7% increase compared with 2024, while the number of admissions remained stable at 11.2 million, according to data from the Romanian Film Center analysed by Cushman & Wakefield Echinox.
The EU unemployment rate rose slightly to 6.0% in 2025, up from 5.9% in 2024, according to new data covering people aged 15-74 in the labour force, according to Eurostat.
Romania's National Commission for Strategy and Prognosis (CNSP) has cut its 2026 economic growth forecast by 0.9 percentage points to just 0.1%, down from the previous 1% projection, citing current macroeconomic conditions.
Enexus, a renewable energy development and construction company, entered 2026 with 210 MW under active construction across Romania, while securing an additional 195 MW pipeline with an estimated value of approximately €150 million.